MEDIFAST INC logged a -0.4% change during today's afternoon session, and is now trading at a price of $74.64 per share. On average, analysts give it a target price of $73.0.
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The small-cap company is based in the United States. MEDIFAST INC currently returns an annual dividend yield of 8.8%.
Make Sure to Consider the Following Before Buying MEDIFAST INC:
-
MEDIFAST INC has moved -38.6% over the last year.
-
MED has a forward P/E ratio of 9.7 based on its EPS guidance of 7.67.
-
Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 15.6%.
-
The company has a price to earnings growth (PEG) ratio of 0.4.
-
Its Price to Book (P/B) ratio is 4.17
MEDIFAST INC Has Irregular Cash Flows
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 188,874 | 14,601 | 174,273 | -2.03 |
| 2022 | 194,570 | 16,681 | 177,889 | 194.83 |
| 2021 | 94,545 | 34,209 | 60,336 | -56.69 |
| 2020 | 145,196 | 5,887 | 139,309 | 87.74 |
| 2019 | 84,261 | 10,058 | 74,203 | 32.8 |
| 2018 | 60,816 | 4,940 | 55,876 |
MEDIFAST INC's free cash flows have a decent average of $113.65 Million over the last 6 years, but they are highly variable since their coefficient of variability is 224.16%. The compounded average growth rate over this period is 22.0%.
